As of Jun 24
| -5.83 / -6.54%|
The 7 analysts offering 12-month price forecasts for GW Pharmaceuticals PLC have a median target of 149.00, with a high estimate of 181.00 and a low estimate of 130.00. The median estimate represents a +78.85% increase from the last price of 83.31.
The current consensus among 6 polled investment analysts is to Buy stock in GW Pharmaceuticals PLC. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.